Cetera Advisors LLC Eli Lilly & CO Transaction History

Cetera Advisors LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $24.9 Million - $33.3 Million	42,003 Added 77.39%	96,275 $74.9 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $3.3 Million - $3.89 Million	6,289 Added 13.11%	54,272 $31.6 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $1.23 Million - $1.69 Million	2,828 Added 6.26%	47,983 $25.8 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $5.73 Million - $7.66 Million	16,329 Added 56.65%	45,155 $21.2 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $42,866 - $50,345	-138 Reduced 0.48%	28,826 $9.9 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $3.23 Million - $3.77 Million	10,052 Added 53.15%	28,964 $10.6 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $641,286 - $730,812	2,163 Added 12.91%	18,912 $6.12 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $509,518 - $598,249	1,828 Added 12.25%	16,749 $5.43 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $183,762 - $228,369	-783 Reduced 4.99%	14,921 $4.27 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $225,749 - $280,156	-1,004 Reduced 6.01%	15,704 $4.34 Million
Q3 2021 Nov 16, 2021	BUY	$221.6 - $272.71 $736,155 - $905,942	3,322 Added 24.82%	16,708 $3.86 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $80,164 - $103,691	444 Added 3.43%	13,386 $3.07 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $113,380 - $146,776	-690 Reduced 5.06%	12,942 $2.42 Million
Q4 2020 Feb 17, 2021	BUY	$130.46 - $172.63 $155,508 - $205,774	1,192 Added 9.58%	13,632 $2.3 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $127,065 - $146,973	869 Added 7.51%	12,440 $1.84 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $241,054 - $290,106	-1,767 Reduced 13.25%	11,571 $1.9 Million
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $330,601 - $409,190	2,777 Added 26.29%	13,338 $1.85 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $135,253 - $167,523	-1,265 Reduced 10.7%	10,561 $1.39 Million
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $1,815 - $1,974	-17 Reduced 0.14%	11,826 $1.33 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $125,525 - $146,519	1,133 Added 10.58%	11,843 $1.31 Million
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $117,543 - $138,357	-1,056 Reduced 8.98%	10,710 $1.39 Million
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $98,169 - $109,979	-927 Reduced 7.3%	11,766 $1.36 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $154,462 - $193,050	1,799 Added 16.51%	12,693 $1.36 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $31,415 - $36,055	-415 Reduced 3.67%	10,894 $934,000
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $15,287 - $18,045	-206 Reduced 1.79%	11,309 $870,000
Q4 2017 Feb 08, 2018	SELL	$81.94 - $87.89 $3,933 - $4,218	-48 Reduced 0.42%	11,515 $973,000
Q3 2017 Nov 16, 2017	SELL	$77.07 - $85.54 $18,728 - $20,786	-243 Reduced 2.06%	11,563 $990,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,806	11,806 $967,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.3 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account